ND-30

N/A

Report date: 2025/06/11 11:11:23
NME

Base Information

Drug NameND-30
Drug Alias Namebeta amyloid synthesis inhibitors (Cenna Biosciences)ND-10ND-20ND-30
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein modulatorsBeta amyloid A4 protein inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCenna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCenna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A